Evidence map›Paper›PMID 30693858›Full record

ArticleThe American journal of tropical medicine and hygiene2019

Potential for Seasonal Lassa Fever Case Exportation from Nigeria.

Ashleigh R Tuite, Alexander G Watts, Moritz U G Kraemer, Kamran Khan, Isaac I Bogoch

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Lassa Fever: Critical Review and Prospects for Control.Tropical medicine and infectious disease · 2024
    Review
  5. Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  6. The niche of One Health approaches in Lassa fever surveillance and control.Annals of clinical microbiology and antimicrobials · 2021
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ashleigh R TuiteDalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Alexander G WattsLi Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
Moritz U G KraemerDepartment of Zoology, University of Oxford, Oxford, United Kingdom.
Kamran KhanDepartment of Medicine, Division of Infectious Diseases, University of Toronto, Toronto, Canada.
Isaac I BogochDivisions of General Internal Medicine and Infectious Diseases, University Health Network, Toronto, Canada.

Funding

CanadianInstitutes of Health Research
6 · The paper itself

Abstract

The largest epidemic of Lassa fever in recent history occurred in Nigeria in 2018. We assessed the potential for cases of Lassa fever originating in Nigeria to arrive at international destinations via air travel using a probabilistic model. We estimated no exported cases in 62% of 1,000 model simulations. In 30% of simulations, a single exported case was projected. Greater than 40% of outbound travelers from Nigeria arrived in the United States, the United Kingdom, and Ghana, placing these countries at greatest risk for receiving an exported case. There was a wide range in the capacity of highly connected countries to respond to infectious disease threats, as measured by the Infectious Disease Vulnerability Index. Although we quantified a low probability of case exportation during this outbreak, countries with the greatest connectivity to Nigeria should be alert to the potential risks of Lassa fever importation and be prepared to manage infected individuals.

Indexed as

SeasonsDisease OutbreaksGlobal HealthHumansLassa FeverNigeriaTravel

Identifiers

PMID30693858
PMCPMC6402922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.